Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3761246 | 0.87 | MEN1 (0.32) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL3761450 | 0.80 | ALDH1A1 (0.34) | CYP2C9CYP2C19 | |
| SCHEMBL3754275 | 0.72 | ALDH1A1 (0.32) | CYP2C9CYP2C19 | |
| SCHEMBL3757052 | 0.72 | LMNA (0.39) | MEN1KMT2ASMN1; SMN2CYP1A2CYP2C9 | |
| SCHEMBL1027343 | 0.70 | MPO (0.33) | MEN1KMT2ASMN1; SMN2CYP1A2CYP2C9 | |
| SCHEMBL4161956 | 0.69 | MPO (0.31) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4171348 | 0.69 | L3MBTL1 (0.32) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4164764 | 0.69 | MEN1 (0.31) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL3754415 | 0.68 | MEN1 (0.33) | MEN1KMT2ASMN1; SMN2CYP1A2CYP2C9 | |
| SCHEMBL3753694 | 0.68 | MEN1 (0.40) | MEN1KMT2ASMN1; SMN2CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298141-A1 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-25 | — | — | US | disclosed |
| EP-2120939-A2 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | E. I. Du Pont de Nemours and Company (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008100426-A2 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298141-A1 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | CYP3A7, CYP2W1, CBR3 | MEN1 3920/4885KMT2A 3291/4885SMN1; SMN2 3285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.